// App-Quantinova.ai

: A new Natural Killer cell therapy to target relapse Acute Lymphoblastic Leukemia (P1135)

Researchers

Presenter

  • Yorleny M Vicioso

Principal Investigators

  • Rose Beck

  • Herman Gram

  • Keman Zhang

  • Abhishek Asthana

  • Derek Wong

  • John Letterio

  • Reshmi Parameswaran

Medical Centers

  • Department of Hematology,

  • Case Western Reserve University School of Medicine, Cleveland, OH

  • Novartis Institutes for BioMedical Research, MA

  • Case Western Reserve University,

  • Cleveland Clinic Foundation,

  • First Department of Pediatrics

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Mismatch repair deficiency

  • Solid malignancies

Biomarkers

  • Natural Killer cells

  • B-cell activating factor

  • Breakpoint Cluster Region

  • Fc gamma RIIIa

  • Transforming growth factor beta

Drug/Treatment

  • Vactosertib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved